ZEOX — Zeo ScientifiX, Inc.
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1557376 ·
Last close
$1.90
Market Cap
$14.78M
52W High
$2.45
52W Low
$1.65
ADV30
9,942
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jan 2026 | 1,446,000 | 1,165,000 | -878,000 | -852,000 | 2,571,000 | 1,030,000 | 2,954,000 |
| Oct 2025 | 1,654,000 | 1,398,000 | -668,000 | -815,000 | 1,527,000 | 221,000 | 2,950,000 |
| Jul 2025 | 1,306,000 | 1,078,000 | -2,071,000 | -2,072,000 | 1,652,000 | 314,000 | 3,966,000 |
| Apr 2025 | 1,149,000 | 893,000 | -1,394,000 | -1,391,000 | 1,435,000 | 542,000 | 3,535,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,254,000
Investing CF
$-14,000
Financing CF
$1,601,000
CapEx
$-14,000
Dividends Paid
—
Buybacks
$-80,000
EPS Diluted TTM
$-0.86
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-68,586,000
Inventory
$502,000
Receivables
$63,000
ST Investments
—
EBIT TTM
$-5,044,000
Pretax Income TTM
$-5,130,000
Interest Exp TTM
$86,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,555,000
EBITDA
$-4,937,000
Free Cash Flow
$420,375
Enterprise Value
$14,718,333
Total Cash
$1,030,000
Total Debt
$349,000
Shares Out
7,777,441
Trailing EPS
$-0.78
Book Value
$-0.05
ROE
—
ROA
-152.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Oct 2025 | 5,199,000 | -5,386,000 | -5,521,000 | 1,527,000 | 2,950,000 | — | -718,000 |
| Oct 2024 | 4,620,000 | -5,319,000 | -4,705,000 | 1,643,000 | 3,296,000 | — | -1,450,000 |
| Oct 2023 | 4,558,000 | -6,768,000 | -6,987,000 | 2,782,000 | 4,023,000 | — | -2,197,000 |
| Oct 2022 | 6,491,008 | -8,842,960 | -8,896,557 | 6,200,688 | 4,312,084 | — | -3,165,840 |
| Oct 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GNTA | Genenta Science S.p.A. | $14.09M | $0.60 | — |
| PHGE | BiomX Inc. | $16.38M | $1.62 | — |
| INAB | IN8BIO, INC. | $16.64M | $1.69 | — |
| INTS | INTENSITY THERAPEUTICS, INC. | $12.65M | $4.68 | — |
| PASG | Passage BIO, Inc. | $17.80M | $5.55 | — |
News headlines (Yahoo Finance, 1h cache)
ZEO ScientifiX Announces That Unaudited Monthly Sales Surpassed $1.0 million in April 2026, the First Time The Company Has Achieved This Milestone.
2026-05-12 11:00 · Yahoo
ZEO ScientifiX Surpasses 500 Physicians Trained in Regenerative Medicine Compliance; Monthly Masterclasses Average 70+ Clinicians
2026-04-21 11:00 · Yahoo
Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics--Powered by an Exclusive Scientific and Biologics Strategic Collaboration
2026-04-09 11:00 · Yahoo
Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration
2026-04-09 11:00 · Yahoo
ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage
2026-04-07 17:56 · Yahoo
Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's Allogeneic Stem Cell Therapy in the United States
2026-01-07 12:45 · Yahoo
ZEO ScientifiX(TM) Positioned for New Growth as Florida Opens Stem Cell Market
2025-10-23 12:30 · Yahoo
ZEO ScientifiX Positions for National Growth as Stem Cell Market Opens in Florida
2025-07-09 12:30 · Yahoo
ZEO ScientifiX Launches Physician-Focused Masterclass Ahead of Florida's SB-1768 Law Implementation
2025-06-24 12:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.